Clinical Trial
Manufacturing.
Phase I, II and III Clinical Supplies Manufactured with Compliance and Quality
Expertise
Our Leadership team has extensive collective experience in steering products from pre-clinical to commercial manufacture.
Science-led
Our approach is scientific, collaborative and open, ensuring an open dialogue and transparency that fits your project.
Award-winning
We are a leading CDMO recognised for numerous awards including a King's Award For Enterprise.
Nimble
We adapt to your project needs, and pledge to never relegating it to the bottom of the list.
MHRA and Home Office Approved
Phase I, II and III Clinical Manufacturing
We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase III clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.
We offer manufacturing and packaging of Investigational Medicinal Products (IMP) in dosage forms including oral solid dosage forms, bulk dry powders, dry powder inhalers, nasal suspensions and solutions; for both biological molecules and small molecules.
10 individual GMP manufacturing suites
GMP manufacturing capabilities
10 individual GMP manufacturing suites, featuring 6 high-potent processing rooms, 3 non-contained processing rooms and a commercial scale processing room.
Expertise built on the world's leading technology
Processing technologies
Our manufacturing process trains are built on the world’s leading technology, from a Gerteis Mini-Pactor to the O’Hara Tablet Coater, a GEA Post Hoist Blender, to the Zanasi Capsule Filler, and the Futorque X to ProCepT and Niro spray dryers.
Collaborative and science-led
Routes of delivery
- Oral (solid, semi-solid and liquid forms)
- Inhaled (nasal and pulmonary)
- Parenteral (sterile fill/finish)
Dosage forms
- Bulk spray dried powders
- Capsules
- Tablets
- Dry Powder Delivery Devices (nasal and pulmonary)
- Liquid Delivery Devices (nasal and pulmonary)
